Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 287

1.

Impairment of photoreceptor ribbon synapses in a novel Pomt1 conditional knockout mouse model of dystroglycanopathy.

Rubio-Fernández M, Uribe ML, Vicente-Tejedor J, Germain F, Susín-Lara C, Quereda C, Montoliu L, de la Villa P, Martín-Nieto J, Cruces J.

Sci Rep. 2018 Jun 4;8(1):8543. doi: 10.1038/s41598-018-26855-x.

2.

Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients.

Medrano LM, Garcia-Broncano P, Berenguer J, González-García J, Jiménez-Sousa MÁ, Guardiola JM, Crespo M, Quereda C, Sanz J, Canorea I, Carrero A, Hontañón V, Muñoz-Fernández MÁ, Resino S; GESIDA 3603b Study Group.

AIDS. 2018 Jun 1;32(9):1095-1105. doi: 10.1097/QAD.0000000000001787.

PMID:
29438197
3.

Expression in retinal neurons of fukutin and FKRP, the protein products of two dystroglycanopathy-causative genes.

Haro C, Uribe ML, Quereda C, Cruces J, Martín-Nieto J.

Mol Vis. 2018 Jan 20;24:43-58. eCollection 2018.

4.

Treatment of hepatitisC virus with direct-acting antivirals: Practical aspects and current situation.

Vivancos MJ, Moreno A, Quereda C.

Rev Clin Esp. 2018 Jan - Feb;218(1):29-37. doi: 10.1016/j.rce.2017.07.006. Epub 2017 Sep 22. English, Spanish.

PMID:
28947060
5.

Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection.

Berenguer J, Rodríguez-Castellano E, Carrero A, Von Wichmann MA, Montero M, Galindo MJ, Mallolas J, Crespo M, Téllez MJ, Quereda C, Sanz J, Barros C, Tural C, Santos I, Pulido F, Guardiola JM, Rubio R, Ortega E, Montes ML, Jusdado JJ, Gaspar G, Esteban H, Bellón JM, González-García J; GESIDA HIV/HCV Cohort Study Group.

Hepatology. 2017 Aug;66(2):344-356. doi: 10.1002/hep.29071. Epub 2017 Jun 22.

6.

Therapeutic variability in adult minimal change disease and focal segmental glomerulosclerosis.

Fernandez-Juarez G, Villacorta J, Ruiz-Roso G, Panizo N, Martinez-Marín I, Marco H, Arrizabalaga P, Díaz M, Perez-Gómez V, Vaca M, Rodríguez E, Cobelo C, Fernandez L, Avila A, Praga M, Quereda C, Ortiz A.

Clin Kidney J. 2016 Jun;9(3):381-6. doi: 10.1093/ckj/sfw028. Epub 2016 May 24.

7.

Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.

Sainz-de-la-Maza S, Casado JL, Pérez-Elías MJ, Moreno A, Quereda C, Moreno S, Corral I.

Eur J Neurol. 2016 May;23(5):919-25. doi: 10.1111/ene.12963. Epub 2016 Feb 23.

PMID:
26914970
8.

Development and Validation of an HIV Risk Exposure and Indicator Conditions Questionnaire to Support Targeted HIV Screening.

Elías MJ, Gómez-Ayerbe C, Elías PP, Muriel A, de Santiago AD, Martinez-Colubi M, Moreno A, Santos C, Polo L, Barea R, Robledillo G, Uranga A, Espín AC, Quereda C, Dronda F, Casado JL, Moreno S.

Medicine (Baltimore). 2016 Feb;95(5):e2612. doi: 10.1097/MD.0000000000002612.

9.

Bone fractures and lumbar mineral density after renal transplantation. A long-term cross-sectional study.

Jiménez S, Marcén R, Vaamonde C, Caballero C, Fernández-Rodríguez A, Villafruela JJ, Galeano C, Teruel JL, Quereda C.

Clin Transplant. 2016 Feb;30(2):131-7. doi: 10.1111/ctr.12666.

PMID:
26546290
10.

Teaching innovations in ultrasound-guided renal biopsy.

Rivera Gorrín M, Correa Gorospe C, Burguera V, Ortiz Chercoles AI, Liaño F, Quereda C.

Nefrologia. 2016;36(1):1-4. doi: 10.1016/j.nefro.2015.07.011. Epub 2015 Oct 31. English, Spanish. No abstract available.

11.

Palliative peritoneal dialysis: Implementation of a home care programme for terminal patients treated with peritoneal dialysis (PD).

Gorrin MR, Teruel-Briones JL, Vion VB, Rexach L, Quereda C.

Nefrologia. 2015;35(2):146-9. doi: 10.1016/j.nefro.2015.05.015. Epub 2015 Jun 23. English, Spanish.

12.

Choosing conservative therapy in chronic kidney disease.

Teruel JL, Burguera Vion V, Gomis Couto A, Rivera Gorrín M, Fernández-Lucas M, Rodríguez Mendiola N, Quereda C.

Nefrologia. 2015;35(3):273-9. doi: 10.1016/j.nefro.2015.05.005. Epub 2015 Jun 18. English, Spanish.

13.

Progressive multifocal leukoencephalopathy mimicking milliary CNS tuberculosis.

Corral I, Quereda C, Dronda F, Navas E, Hermida JM, Moreno C, Martínez-San-Millán J.

J Neurovirol. 2015 Dec;21(6):691-3. doi: 10.1007/s13365-015-0367-6. Epub 2015 Aug 5. No abstract available.

PMID:
26242918
14.

Brief Report: Reduced Cell-Associated HTLV-2 DNA in Antiretroviral Treated HIV-1-HCV-Coinfected Patients Who Either Received Interferon-α/Ribavirin-Based Hepatitis C Therapy or Had Spontaneous HCV RNA Clearance.

Abad-Fernández M, Dronda F, Moreno A, Casado JL, Pérez-Elías MJ, Quereda C, Moreno S, Vallejo A.

J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):286-90. doi: 10.1097/QAI.0000000000000608.

PMID:
26181704
15.

Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis.

Casado JL, Mena A, Bañón S, Castro A, Quereda C, Moreno A, Pedreira J, Moreno S.

HIV Med. 2016 Jan;17(1):62-7. doi: 10.1111/hiv.12274. Epub 2015 Jun 30.

16.

Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response.

Casado JL, Esteban MA, Bañón S, Moreno A, Perez-Elías MJ, Mateos ML, Moreno S, Quereda C.

Dig Dis Sci. 2015 Nov;60(11):3473-81. doi: 10.1007/s10620-015-3773-y. Epub 2015 Jun 26.

PMID:
26112991
17.

Association of baseline CD4+ cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients.

Aldámiz-Echevarría T, González-García J, Von Wichmann MA, Crespo M, López-Aldeguer J, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Bellón JM, Montes M, Berenguer J.

Ann Hepatol. 2015 Jul-Aug;14(4):464-9.

18.

Hydrothorax secondary to a malpositioned peritoneal dialysis catheter.

Gorrín MR, Rodríguez-Mendiola N, Saico SP, de Nicolás VD, Rioja ME, Quereda C.

Perit Dial Int. 2015 May-Jun;35(3):365-6. doi: 10.3747/pdi.2014.00133. No abstract available.

19.

Black esophagus in the early kidney post-transplant period.

Caravaca-Fontán F, Jimenez S, Fernández-Rodríguez A, Marcén R, Quereda C.

Clin Kidney J. 2014 Dec;7(6):613-4. doi: 10.1093/ckj/sfu094. Epub 2014 Sep 14. No abstract available.

20.

Effects of a single, high oral dose of 25-hydroxycholecalciferol on the mineral metabolism markers in hemodialysis patients.

Merino JL, Teruel JL, Fernández-Lucas M, Villafruela JJ, Bueno B, Gomis A, Paraíso V, Quereda C.

Ther Apher Dial. 2015 Jun;19(3):212-9. doi: 10.1111/1744-9987.12279. Epub 2015 Feb 6.

PMID:
25656524

Supplemental Content

Loading ...
Support Center